Takeaways: The decision is especially meaningful for CELYSTRA because Québec is a high-prevalence region for FCS among French Canadians, so public coverage can quickly translate into concentrate...
Canada’s biotechnology industry is entering a defining era of scientific innovation, global investment, and clinical excellence. The Leading 10 Canadian Biotech Companies of 2026 report highligh...
